Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)

COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the curr...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Gorman, Philip, Norris, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228576/
https://www.ncbi.nlm.nih.gov/pubmed/34168043
http://dx.doi.org/10.1136/bmjgast-2020-000568
_version_ 1783712774476529664
author O'Gorman, Philip
Norris, Suzanne
author_facet O'Gorman, Philip
Norris, Suzanne
author_sort O'Gorman, Philip
collection PubMed
description COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to suppress the spread of COVID-19 on exercise and physical activity participation in patients with NAFLD. The future of exercise prescription and the potential use of digital technology in addressing NAFLD healthcare needs in the COVID-19 era are also explored.
format Online
Article
Text
id pubmed-8228576
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82285762021-06-28 Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD) O'Gorman, Philip Norris, Suzanne BMJ Open Gastroenterol Communication COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to suppress the spread of COVID-19 on exercise and physical activity participation in patients with NAFLD. The future of exercise prescription and the potential use of digital technology in addressing NAFLD healthcare needs in the COVID-19 era are also explored. BMJ Publishing Group 2021-06-24 /pmc/articles/PMC8228576/ /pubmed/34168043 http://dx.doi.org/10.1136/bmjgast-2020-000568 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Communication
O'Gorman, Philip
Norris, Suzanne
Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title_full Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title_fullStr Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title_full_unstemmed Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title_short Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title_sort exercising in the covid-19 era: implications in non-alcoholic fatty liver disease (nafld)
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228576/
https://www.ncbi.nlm.nih.gov/pubmed/34168043
http://dx.doi.org/10.1136/bmjgast-2020-000568
work_keys_str_mv AT ogormanphilip exercisinginthecovid19eraimplicationsinnonalcoholicfattyliverdiseasenafld
AT norrissuzanne exercisinginthecovid19eraimplicationsinnonalcoholicfattyliverdiseasenafld

Ejemplares similares